Literature DB >> 22232361

Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination.

Vitali Pool, Daniel M Gordon, Michael Decker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22232361     DOI： 10.1001/archneurol.2011.1519

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  3 in total

1. 

Authors:  Norbert Wagner; Frauke Assmus; Gabriele Arendt; Erika Baum; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Dirk Föll; Edeltraut Garbe; Jane Hecht; Ulf Müller-Ladner; Tim Niehues; Klaus Überla; Sabine Vygen-Bonnet; Thomas Weinke; Miriam Wiese-Posselt; Michael Wojcinski; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

Review 2.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682

3.  Risk of MS relapse after yellow fever vaccination: A self-controlled case series.

Authors:  Angela Huttner; Gilles Eperon; Agustina M Lascano; Serge Roth; Jean-Marc Schwob; Claire-Anne Siegrist; Patrice H Lalive
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.